Steven Quay, MD, PhD Profile
Steven Quay, MD, PhD

@StevenQuay

Followers
2K
Following
16
Media
14
Statuses
256

Physician-Scientist, Inventor, Author, TEDx Speaker, and Serial Entrepreneur

Seattle, WA
Joined April 2009
Don't wanna be here? Send us removal request.
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
2 years
RT @atossainc: Atossa Therapeutics to Participate in Tribe Public’s Webinar Event “Redefining Breast Cancer Prevention and Treatment” https….
0
6
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
2 years
RT @atossainc: Atossa Therapeutics Announces Year-End 2022 Financial Results and Provides Corporate Update
0
7
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
2 years
RT @atossainc: Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clin….
0
8
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
2 years
RT @atossainc: Atossa to Present at the Sidoti Small-Cap Virtual Conference
0
3
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
2 years
RT @atossainc: Atossa Doses First Patient in Phase 2 Neoadjuvant Clinical Study of (Z)-Endoxifen in Premenopausal Women with ER+/HER2- Brea….
0
18
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
2 years
RT @atossainc: Atossa Therapeutics Further Strengthens Intellectual Property Portfolio with Additional Broad Patent for Endoxifen https://t….
0
8
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
2 years
RT @atossainc: Atossa Therapeutics Issues Letter to Shareholders
0
10
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics Announces the Appointment of Eric Van Zanten as Vice President, Investor and Public Relations https://t.….
0
7
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
0
4
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics, Inc. to Acquire Stake in Privately Held Dynamic Cell Therapies as Part of Overall CAR-T Strategy https:….
0
6
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics, Inc. Announces Appointment of Pharma Industry Veteran Richard Graydon, M.D., Ph.D. .
0
7
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics, Inc. Receives Authorization from FDA to Initiate its Phase 2 Study of Neoadjuvant (Z)-endoxifen in Prem….
0
10
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics, Inc. to Attend the 24th Annual H.C. Wainwright Global Investment Conference
0
3
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Registration Now Open for Tribe Public’s Webinar Event “The Important Role For Inhalation Therapy In Oncology” Featuring The….
0
2
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics Appoints Dr. Paul Wabnitz to Its Scientific Advisory Board
0
4
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
0
6
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics, Inc. Receives Authorization from FDA to Initiate its Phase 2 Study of Neoadjuvant (Z)-endoxifen in Prem….
0
9
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics, Inc. to Attend the 24th Annual H.C. Wainwright Global Investment Conference
0
3
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Registration Now Open for Tribe Public’s Webinar Event “The Important Role For Inhalation Therapy In Oncology” Featuring The….
0
6
0
@StevenQuay
Steven Quay, MD, PhD
@StevenQuay
3 years
RT @atossainc: Atossa Therapeutics Appoints Dr. Paul Wabnitz to Its Scientific Advisory Board
0
7
0